Empowering meaningful conversations in MedTech.

Giovanni Lauricella has a Bachelor’s in Finance and a Master’s in Regulatory Affairs in Medical Devices. He has travelled to 40+ countries and has assisted 500+ startups with talent acquisition and fundraising strategies leading to more than 2,000 hires, $300 million in raised capital, and $4 billion in acquisitions. Giovanni is an active board member and angel investor, who brings 15 years of experience designing and building teams for MedTech startups.

Diana Saraceni is Co-Founder & General Partner at Panakes, a Venture Capital firm dedicated to early-stage investments in Life Sciences primarily in Europe and the US. With over 20 years of Venture Capital experience, she has also co-founded and managed 360 Capital Partners, another leading pan-European Venture Capital firm. She has led investments in a significant number of companies all over Europe, not only in the Life Sciences sector, and generated several exits as IPO and M&A transactions. Diana is also part of several committees in Europe and in the US for public/private grants and awards allocation to start-ups. She also follows several portfolios in neuroscience, oncology, endoscopy, tissue regeneration, ophthalmology and pain.

Kwame Ulmer is the Managing Partner at MedTech Impact Partners. Kwame brings over two decades of experience evaluating medical technologies in the government and private sector. He is also a Venture Partner at Wavemaker Three-Sixty Health. He leads the MedTech practice and participates in all aspects of fund management (e.g. deal sourcing, diligence, negotiation, and advising portfolio company management teams). He is also a venture partner at Wavemaker Three-Sixty Health. He leads the medtech practice and participates in all aspects of fund management (e.g. deal sourcing, diligence, negotiation, and advising portfolio company management teams)

Catello Somma is a Partner at Seroba. He has a background in venture capital and clinical development, with a focus on the biotechnology and medical device industries. Catello graduated in 2007 summa cum laude from the University of Naples Federico II and in 2014 completed an MBA at POLIMI Graduate School of Management.

Gautam is a Partner at TCP Health Ventures (part of The Capital Partnership Group with AUM of US$ 7 billion) and focuses on early stage investments in medtech space. Gautam serves as a member of Board of Directors for Tioga Cardiovascular Inc., Adona Medical Inc., Plexaa Limited, and Akura Medical Inc. Gautam has over 20+ years of experience in private investments space across various geographies (US, Europe, Asia, and Africa) with total deployed capital of $1+ billion.

Dr. Swarna Balasubramaniam is a surgeon, inventor and medical device entrepreneur. She is the founder of Noleus Technologies, medical device company focused on developing and commercializing innovative technologies intended to accelerate recovery and to improve outcomes after surgery. The first product aims to establish a new standard of care for post-operative ileus through its’ differentiated and proprietary technology to reliably accelerate the return of bowel function after abdominal surgery. She is a board certified surgeon and has 20 years of experience as a practicing surgeon . She was raised in the Boston MA, and completed medical school and general surgery training at the Mayo Clinic in Rochester MN. She worked as a general surgeon at Kaiser Permanente for two years prior to completing a colon & rectal surgery fellowship at The University of Southern California in Los Angeles. She has experience in basic science research in the areas of radiologic imaging, cardio-renal physiology, molecular oncology and in clinical translational surgical research.

Daniel is the Founder & CEO of SonoVascular. He has over 35 years of global healthcare experience with a successful track record of building and growing medical technology businesses. Daniel has held senior leadership positions in general management and business development with leading healthcare companies, including Abbott and J&J. He received his BS in Business Administration from Syracuse University and his MBA from the University of Miami.

Dr. Spencer Todd has spent his years at FDA, large medical device manufacturers, and as a consultant bringing medical devices to market in the US and the European Union. Spencer founded FormlyAI to create innovative software that provides a fast and affordable option for medical device certification that founders need.

Dr. Gershony is an internationally recognized interventional cardiologist and serial MedTech entrepreneur. He was the Founder of Vascular Solutions, helped lead a successful IPO in 2000, and served as the company’s Chief Medical Officer and Board member. He subsequently co-founded AngioScore which developed novel angioplasty scoring balloons and served as Chief Medical Office and Board member until its acquisition in 2014. Dr. Gershony is a Founding General Partner at BayMed Venture Partners which is based in San Francisco. He currently serves on the boards of multiple medical device companies and is a frequent speaker at investor conferences

Dr. Khulood Alsayegh, MD, is an accomplished healthcare leader and regulatory advisor, Head of Clinical Standards and Guidelines with Dubai Health Authority, a non- resident fellow researcher with Mohamed Bin Rashid School of Governance and consultant Family Physician. Qualified at the Royal College of Surgeons in Ireland and Harvard Medical school, Boston. She has 20 years of clinical experience in the United States, Europe, the GCC and the United Arab Emirates. Pioneer in Telehealth and AI ethics, certified as the first ethical Lead Assessor in healthcare within the Middle East and Africa, by IEEE. Participated as a speaker in multiple local and international conferences. Won multiple international awards and is currently leading the ongoing development of clinical standards for application to both private and public sectors across the emirate of Dubai.

Alex Condon is a co-founder of Galen Data, a medical device cloud data platform. Previously, Alex was the Chief Strategy officer at Tietronix Software, a NASA contractor focusing on Life Sciences innovations. Alex has represented Healthcare and Space technologies on six Mayor-led international trade missions for the City of Houston.

A medical device executive with 20 years of experience developing high impact innovative medical devices and an author of 90+ US patents and patent applications.
An early employee of Baylis Medical (acquired by Boston Scientific), Sadra Medical (acquired by Boston Scientific), Symetis (acquired by Boston Scientific) and co-founder of AboGen (acquired by Orasure Technologies). Co-founder of Anchor Orthopedics, a commercial stage medical device company, CEO of BariaTek, an obesity company, and CEO of Holistick Medical, a structural heart company.

Pablo is a former pharma executive and entrepreneur turned investor with CG Health Ventures, investing in early stage medtech and healthtech globally. Its portfolio spans from diagnostics to medical devices and software, and includes over 17 active investments with a strong focus in the USA.

Dave Marver serves as CEO of ONWARD Medical, a highly innovative medical technology company developing therapies for people with spinal cord injury. ONWARD has 10 FDA Breakthrough Device Designation Awards and over 240 issued patents covering its neuromodulation and brain-computer interface platforms.

Dr. Albert Huang is a surgeon, founder and CEO of Allotrope Medical which was acquired in 2023. With a lifelong passion for solving problems, creative design, and entrepreneurship, he has found success both in the academic setting as well as within medtech innovation.

Darcy Bachert is the Founder and CEO of Prolucid, an ISO 13485 certified software engineering firm that specializes in custom medical software development. Over the past 16 years Darcy has grown Prolucid to a team of 25, supporting innovative medtech companies across the world in successfully bringing their applications and devices to market.

John is an accomplished healthcare leader with over a decade of experience collaborating with health systems, healthcare partners, and early-stage companies. His expertise spans strategic venture capital investments, innovation, advisory services, and financial consulting. Currently, as a Managing Director at Rex Health Ventures (RHV), he co-leads the corporate venture arm of UNC Health, driving a culture of innovation and delivering financial returns through strategic equity investments in early-stage companies.

Professor Shafi Ahmed is a world-renowned, multi-award-winning surgeon, teacher, futurist, innovator,entrepreneur, humanitarian, and an international keynote speaker. He is a 3x TEDx speaker and has deliveredover 350 keynotes in over 40 countries.After studying medicine at Kings College Hospital Medical School London, he completed his surgical training inLondon. He was appointed as a laparoscopic colorectal surgeon specialising in colorectal cancer at The RoyalLondon and St Bartholomew’s Hospitals.He is a serial entrepreneur and is the CEO of Medical Realities, an award-winning AI-powered XR medicaleducation company. He was appointed Chief Medical Metaverse Officer at AIMEDIS, building the world’s firsthealth metaverse. He also cofounded GIANT Health, the largest medical technology conference in the UK.He has received multiple professorships and honorary doctorates and was a Nobel Peace Prize nominee in2020 for his humanitarian work in conflict zones for over a decade. In 2018, he was awarded the Future NHSaward for NHS70 by Members of Parliament. In 2017, he was the top British Asian star in Tech. He was also theBritish Bangladeshi of the Year 2017.He recently launched the Shafi Ahmed Foundation International as an advocate for equality and a passion forhumanitarian projects. This foundation aims to provide relief and aid to those in need whilst promoting accessto medical training.

Dr. Chiang is the first Chief Medical Officer for the Endoscopy business of Medtronic, the global leader in health technology. He is also currently an Assistant Professor of Medicine at an academic teaching hospital in Philadelphia, PA, and serves as the Director of the Endoscopic Weight Loss Program. He completed his undergraduate studies at Duke University before earning his MD at Columbia University. He stayed for Internal Medicine residency at New York Presbyterian Hospital and completed his GI and bariatric endoscopy fellowships at Brigham and Women’s Hospital. He obtained his MPH from the Harvard TH Chan School of Public Health before completing an advanced endoscopy fellowship at Jefferson.

Dr. Gelvan is a seasoned life-science executive, investor and venture-builder with over thirty years of experience in healthcare and deep-tech. Dan is CEO of leading AI-based pesticide development company, AgPlenus and CEO of t-syte, an early-stage digital health VC venture lab. Dan holds a Ph.D. in Business Economics from Roskilde University, Denmark.

Prior to Vista, Daniel was CEO of Avail Medsystems and held roles at Advanced Cardiovascular Systems, Endologix, Restore Medical, EnteroMedics, and Intuitive Surgical where was the 6th employee. Daniel co-founded Calibra Medical, and founded Shockwave Medical (NYSE: JNJ), where he invented IVL and served as CEO. He is an inventor on 160 patents and applications.

Dr. Irit Yaniv (MD, MBA), is an experienced and accomplished senior executive in the Medtech industry; Currently a Co-Founder and CEO of Almeda Ventures. She is still involve in Accelmed venture and PE investments. Irit is heavily involved in the Israeli Eco-System, taking an active part in academia and various industry conferences as well as promoting women leadership.

Kevin is passionate about innovation, solving complex problems in the MedTech world, and having conversations about novel ideas. Kevin started his career developing point-of-care diagnostic solutions for oncology and infectious diseases in his Ph.D. work. As a brand founder in the MedTech business intelligence space, he now spends his days understanding the unmet needs in the MedTech & SaaS industry. Ask him about his early life in Cambodia.

With nearly twenty years’ experience in raising capital, Thom has spent the last decade of his career focusing on the medical device ecosystem. An industry-dedicated investment banker and strategic advisor, Thom has advised dozens of growth stage medical device and related service companies on exit-planning and capital raising initiatives.

Yoav Fisher works at HealthIL, the governmental ecosystem for healthcare innovation in Israel. HealthIL works across all stakeholders to improve care through successful integration of startups and technology for the benefit of citizens globally. Prior to HealthIL Yoav worked in venture and continues to support early-stage health-tech startups through angel investments.

With 25+ years in the health industry, I am a business communications expert, networker, and serial entrepreneur. As Managing Partner at FINN Partners, I provide integrated solutions for biotech and medtech organizations. As a C-level industry expert, I have led significant outsourcing solutions from molecule to market and served as a strategic advisor to C-suite and investor stakeholders, supporting fundraising efforts for emerging companies globally. I have also driven change initiatives, such as the internal communications for the merger of two device clients and the ongoing integrated engagement for a major corporate transformation. I also am the co-founder of Alverium Health, a global contract biotech organization (CBO) that has developed a unique approach to the commercialization journey. Our mission is to accelerate the development and delivery of innovative therapies that improve patients’ lives and address unmet medical needs.

Dr. Sascha Berger leads NEOM’s biotech and medtech investments, bringing nearly 20 years of experience to the role. Based in Saudi Arabia, he drives innovation in life sciences through strategic investments, supporting groundbreaking technologies globally. Previously, he was a General Partner at TVM Capital Life Science, focusing on advancing healthcare innovation.

Osama Alsaleh, Head of Partnerships at Plug and Play Health, is a healthcare leader advancing global solutions through strategic collaborations. With expertise in healthcare IT, venture capital, innovation and health equity, he has previously led Oracle’s health equity team and represented them on the White House Covid-19 Taskforce. Osama studied at George Washington University and Harvard and speaks 4 languages.

Dr. Tosin Sotubo-Ajayi is a medical doctor with over a decade of clinical experience, specialisingin women’s Health. She is a healthtech advisor, health educator, and public speaker, passionateabout the intersection of health technology. She was selected as a UK NHS Clinical Entrepreneurfor her innovative focus on healthcare and technology. Currently, she serves as Senior MedicalAdvisor for Flo Health, the leading female health app globally, and serves as an advisory mentorfor FemTech Lab, Europe’s first FemTech-focused start-up accelerator programme. Additionally,Dr. Sotubo-Ajayi has worked as a prominent TV Doctor in the UK and is a sought-after publicspeaker, inspiring audiences on many notable platforms.